Trial intelligence / Profile preview

Piperacillin vs Placebo in Acute Cholecystitis Surgery

NCT02619149Phase 3Completed

Sponsor
Karolinska Institutet
Start
Mar 2009
Primary completion
Dec 2017
Modality
Irreversible Covalent Inhibitors
Countries
1
01

Overview

A Phase 3 trial of piperacillin + tazobactam in acute cholecystitis, sponsored by Karolinska Institutet. Started Mar 2009; status: completed.

02

Drugs

piperacillin + tazobactam
03

Conditions

acute cholecystitis

Beyond the preview

Go deeper on NCT02619149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02619149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call